Skip to main content
# Title Department Research Year
181 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
182 Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents Department of Pharmaceutical Organic Chemistry 2023
183 Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
184 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
185 Synthesis and antiproliferative Potential of thiazole and 4-thiazolidinone Containing Motifs as dual inhibitors of EGFR and BRAFV600E Department of Pharmaceutical Organic Chemistry 2023
186 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
187 Fully functional monocytic MDSC generation from the murine HoxB8 cell line 2023
188 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
189 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
190 Discovery and optimization of 2, 3-diaryl-1, 3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023